Overview of Dr. Hsu
I am a board certified hematologist specializing stem cell transplant and cellular therapy. I completed my hematology/oncology fellowship at Hospital of University of Pennsylvania.
Office
520 East 70th Street
Starr Pavilion, 3rd Floor
New York, NY 10021
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008
State University of New York Downstate Medical Center College of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2025
PA State Medical License 2008 - 2016
NJ State Medical License 2006 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 4 citationsXPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.Rossella Marullo, Sarah C Rutherford, Maria V Revuelta, Nahuel Zamponi, Biljana Culjkovic-Kraljacic
Cancer Research. 2024-01-02 - 4 citationsNext-Generation Chimeric Antigen Receptor T-cells.Dongni Yi, Mia Gergis, Jingmei Hsu, Yang Yang, Xia Bi
Hematology/oncology and Stem Cell Therapy. 2022-12-15 - 216 citationsLong-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, ph...Stephen J. Schuster, Constantine S. Tam, Peter Borchmann, Nina Worel, Joseph P. McGuirk
The Lancet. Oncology. 2021-10-01
Abstracts/Posters
- Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...Jingmei Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationJingmei Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
First Woman to Receive Stem Cell Transplant for HIV Remains Virus-Free 5 Years LaterMarch 17th, 2023- Another Person Cured of HIV Disease - but It Is a Special CaseMarch 17th, 2023
- Umbilical Blood Stem Cell Transplant Puts Woman in HIV RemissionMarch 16th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
